Drug Use and Addiction Research Programs in New Jersey
Drug Use and Addiction Research Programs (93.279) awarded $106 million to recipients in New Jersey in 96 grants from fiscal 2021 to 2025, 1.4% of the program's national total. Rutgers the State University of New Jersey received the most, $43.8 million.
- Awarded in New Jersey$106 million
- Awards96
- Share of the program1.4%
- Rank among states18th of 50
- National total$7.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 35 | $17.2 million |
| FY 2022 | 41 | $17.9 million |
| FY 2023 | 40 | $22.5 million |
| FY 2024 | 47 | $23.8 million |
| FY 2025 | 48 | $24.5 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 38 | $43.8 million |
| The Trustees of Princeton University | Colleges and universities | 11 | $16.9 million |
| Adneuris Therapeutics Inc. | Small businesses | 1 | $6.7 million |
| Tonix Pharmaceuticals, Inc. | Small businesses | 1 | $5.2 million |
| Rutgers, the State University | Colleges and universities | 5 | $4.9 million |
| Rutgers, the State University | Colleges and universities | 10 | $4.6 million |
| Rowan University | Colleges and universities | 5 | $3.4 million |
| Intra-Cellular Therapies, Inc. | Businesses | 1 | $2.9 million |
| Enalare Therapeutics Inc | Small businesses | 1 | $2.8 million |
| Plumeria Therapeutics Inc | Small businesses | 2 | $2.2 million |
Open opportunities under this program
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
See all 109 on the program page
Questions people ask
How much Drug Use and Addiction Research Programs money goes to New Jersey?
$106 million from fiscal 2021 to 2025, across 96 awards. New Jersey ranks 18th of 50 states and territories for this program.
Who receives Drug Use and Addiction Research Programs money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $43.8 million in 38 awards. Next are The Trustees of Princeton University and Adneuris Therapeutics Inc..
Can organizations in New Jersey apply now?
Yes, 109 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Drug Use and Addiction Research Programs in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies